Search Videos and More
TAVR keeps improving outcomes for aortic stenosis
Transcatheter aortic valve replacement (TAVR) has been an alternative to open surgery for decades. But many don’t know about its stunning results in reducing complications. Learn more from one of the nation’s leading TAVR experts.Pulsed field ablation: The new first-line AFib treatment
Ablation procedures can improve AFib if patients are treated early enough. Pulsed field ablation is a new technology that offers this benefit with less risk of serious complications. Learn how it’s transforming the AFib treatment landscape.Tips to detect CVD earlier in women
Women with cardiovascular disease (CVD) tend to receive later diagnoses and less aggressive treatment than men. Learn the unique signs of CVD in women and when to refer.Women treating high risk indicated patients (WHiP) conference
In April 2024, WellSpan York Hospital hosted the second annual Women Treating High Risk Indicated Patients (WHiP) conference, bringing together 21 female cardiologists while streaming to more than 75 cardiologists in five countriesMaximizing VAD benefits: The critical role of timely referral
Many heart failure patients who need a ventricular assist device (VAD) don’t get one until their condition has advanced too far. Learn the nuances of advanced heart failure symptoms and when to refer patients for VAD evaluation.Catching abdominal aortic aneurysms before they burst
An abdominal aortic aneurysm (AAA) screening is recommended for men ages 65-75 who are or were smokers. Women with risk factors like a family history may also benefit. Find out who to screen for AAA, how to manage it and when to refer.Cutting-edge clinical trials close to home
WellSpan Health has more than 130 open clinical trials, bringing world-class research to patients in their own backyard. Learn about three trials that help patients reduce dementia risk, manage chronic pain and get better lung cancer screening.Should we do genetic screening for CVD and other diseases?
Screening asymptomatic patients for CVD-causing genes can save lives, but many scientific and ethical questions must be answered before we know it’s worth it.One-of-a-kind stroke prevention for patients with Afib
WellSpan is the first-in-the-US to anchor an in-lab 4D-CT imaging modality to ensure devices are positioned properly.TAVR Q&A with Dr. James Harvey
Dr. Harvey is the “doctor that other doctors come to” to learn the most advanced technique for TAVR. He’s been all over the world, in fact, teaching other interventional cardiologists his approach, which has become the standard of care for this procedure.Ultramodern care for inherited cardiovascular diseases
WellSpan Health’s Center for Inherited Cardiovascular Diseases offers the latest, most advanced treatments for genetic cardiac disorders through precision medicine, novel approaches, genetic testing, advanced research and a multidisciplinary team approach.Paving the way for optimal LAAO procedure outcomes
WellSpan health is a national leader in left atrial appendage occlusion (LAAO) research, technology and procedures. Their aim is to reduce stroke risk in atrial fibrillation (Afib) patients who are not amenable to anticoagulation.